Cookies used for improved website experience

Siemens Healthineers and our partners use cookies and other similar technologies to operate the Siemens Healthineers websites and personalize content and ads. You may find out more about how we use cookies by clicking "Show details" or by referring to our Cookie Policy.
You may allow all cookies or select them individually. And you may change your consent and cookie preferences anytime by clicking on the "Review and change your consent" button on the Cookie Policy page.

Implementing Best Practices in Fatty Liver Disease

Medscape Education Diabetes & Endocrinology

Dr. Kenneth Cusi
Professor of Medicine
Chief, Division of Endocrinology, Diabetes, and Metabolism

The University of Florida, Gainesville, Florida

Medscape Education Diabetes & Endocrinology

|2022-06-23

Join Dr. Cusi in this CME program to learn more about current guideline recommendations to identify and diagnose patients at risk of developing NASH, how to assess the risk of NASH progression and liver-related events, as well as recommendations for current and emerging therapies to effectively manage these patients. 

  • Know the recent clinical guideline recommendations on diagnosis of liver fibrosis
  • Know the recent evidence and recommendations regarding new and emerging therapies
  • Understand the implementation of noninvasive tests for liver fibrosis in clinical practice